NewGenIvf Group Ltd Files 6-K Report

Ticker: NIVFW · Form: 6-K · Filed: Jun 3, 2024 · CIK: 1981662

Newgenivf Group LTD 6-K Filing Summary
FieldDetail
CompanyNewgenivf Group LTD (NIVFW)
Form Type6-K
Filed DateJun 3, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: filing, foreign-issuer, company-update

TL;DR

NewGenIvf Group Ltd (formerly ASPAC I Mini Acquisition Corp.) filed a 6-K on 6/3/24 with a press release.

AI Summary

NewGenIvf Group Limited, formerly ASPAC I Mini Acquisition Corp., filed a Form 6-K on June 3, 2024. The filing includes a press release as Exhibit 99.1. The company is incorporated in D8 and its principal executive office is located in Bangkok, Thailand.

Why It Matters

This filing indicates ongoing reporting activity for NewGenIvf Group Limited, providing updates to investors and the market.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that typically contains press releases or other periodic information, not usually indicative of immediate high risk.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have filed or are required to file with a stock exchange on which their securities are traded.

When was NewGenIvf Group Limited formerly known as?

NewGenIvf Group Limited was formerly known as ASPAC I Mini Acquisition Corp., with a date of name change on June 14, 2023.

Where is NewGenIvf Group Limited's principal executive office located?

The company's principal executive office is located at 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke), Khlong Toei Nuea Sub-district, Watthana District, Bangkok 10110, Thailand.

What exhibit is included with this 6-K filing?

Exhibit 99.1, a Press Release, is included with this 6-K filing.

Who signed this Form 6-K on behalf of NewGenIvf Group Limited?

The Form 6-K was signed by Wing Fung Alfred Siu, pursuant to the requirements of the Securities Exchange Act of 1934.

Filing Stats: 164 words · 1 min read · ~1 pages · Grade level 12.8 · Accepted 2024-06-03 16:30:04

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2024 Commission File Number 001-42004 NEWGENIVF GROUP LIMITED (Translation of registrant’s name into English) 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBITS Exhibit No. Description 99.1 Press Release 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NewGenIvf Group Limited By: /s/ Wing Fung Alfred Siu Name: Wing Fung Alfred Siu Title: Chairman of the Board and Director Date: June 3, 2024 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing